Drug intelligence / Profile preview

acetaminophen + codeine + doxylamine

Development stage
Unknown
Lead developer
Sanofi
Modality
Small Molecules
Administration
Oral
01

Overview

**Acetaminophen + codeine + doxylamine** is a combination pharmaceutical drug used for relief of mild to moderate pain often associated with tension, headache, migraines, dental pain, muscle pain, nerve pain, period pain, or flu symptoms[1][9][10]. - **Acetaminophen** acts as an analgesic and antipyretic, reducing pain and fever. Its mechanism is believed to involve inhibition of prostaglandin synthesis in the central nervous system. - **Codeine** is an opioid analgesic that works by activating mu-opioid receptors in the central nervous system, inhibiting transmission of pain signals[7]. - **Doxylamine** is a first-generation antihistamine with pronounced sedative effects, acting as an antagonist at histamine H1 receptors to relieve symptoms of allergy and enhance the calmative effects of the combination[1][9]. Combined, these agents provide synergistic analgesia and sedation, suitable for situations needing both pain relief and calmative effects. This combination is marketed under several brand names, with formulations typically consisting of acetaminophen 325 mg, codeine phosphate 8 mg, and doxylamine succinate 5 mg per tablet[1][9].

Brand names
MersyndolAPOHEALTH Paracetamol Plus Codeine and Calmative
Other names
acetaminophen + codeine phosphate + doxylamine succinateparacetamol + codeine + doxylamine succinate
02

Targets

DOR (Opioid Receptor Delta 1)KOR (Kappa opioid receptor)CNR1 (Cannabinoid receptor 1)HRH1 (Histamine H1 Receptor)TRPV1 (Transient receptor potential cation channel subfamily V member 1)MOR (Mu opioid receptor)COX POX site (Prostaglandin-endoperoxide synthase 1 (COX-1) peroxidase site)

Beyond the preview

Go deeper on acetaminophen + codeine + doxylamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetaminophen + codeine + doxylamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call